✦ LIBER ✦

Endocrine agents in the treatment of advanced breast cancer

✍ Scribed by I. Bauerfeind; M. Untch

Publisher: Springer
Year: 1999
Tongue: German
Weight: 178 KB
Volume: 32
Category: Article
ISSN: 0017-5994
DOI: 10.1007/pl00003272

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitoxantrone: An active new agent in the

Mitoxantrone: An active new agent in the treatment of advanced breast cancer

✍ Robin C. Stuart-Harris; Thomas Bozek; Nicholas A. Pavlidis; Ian E. Smith 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 432 KB

Fluoxymesterone in the treatment of adva

Fluoxymesterone in the treatment of advanced breast cancer

✍ B. J. Kennedy 📂 Article 📅 1957 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 2 views

Castration in the treatment of advanced

Castration in the treatment of advanced breast cancer

✍ Edward F. Lewison 📂 Article 📅 1965 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 2 views

Trilostane in the treatment of advanced

Trilostane in the treatment of advanced breast cancer

✍ C. G. Beardwell; A. C. Hindley; P. M. Wilkinson; I. D. H. Todd; G. G. Ribeiro; d 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 284 KB

Treatment of advanced male breast cancer

✍ William G. Kraybill; Richard Kaufman; David Kinne 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB 👁 2 views

The modalities used to treat 27 male patients with metastatic breast cancer at Memorial Hospital from 1957-1979 are reviewed. The overall objective orchiectomy response rate was 48% (11123). The median response was 11 months (6-96 months). The median survival in responders was 58 months, whereas the

Trioxifene mesylate in the treatment of

Trioxifene mesylate in the treatment of advanced breast cancer

✍ Raymond W. Lee; Aman U. Buzdar; George R. Blumenschein; Gabriel N. Hortobagyi 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB 👁 2 views